Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.50 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.50 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 10/20 | 0.46 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.46 |
| ▸ | TASP1 | Q9H6P5 | 1/20 | 0.43 |
| ▸ | CTSD | P07339 | 3/20 | 0.43 |
| ▸ | TFPI | P10646 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31497376 | 0.94 | ERBB2 (0.51) | SIRT2SIRT5ERBB2BACE1BACE2 | |
| SCHEMBL31497363 | 0.94 | TASP1 (0.47) | SIRT2SIRT5ERBB2BACE1BACE2 | |
| SCHEMBL31497379 | 0.94 | ERBB2 (0.48) | SIRT2SIRT5ERBB2BACE1BACE2 | |
| SCHEMBL31497336 | 0.93 | ERBB2 (0.48) | SIRT2SIRT5ERBB2BACE1BACE2 | |
| SCHEMBL31497324 | 0.92 | ERBB2 (0.48) | SIRT2SIRT5ERBB2BACE1BACE2 | |
| SCHEMBL31497375 | 0.91 | ERBB2 (0.48) | SIRT2SIRT5ERBB2BACE1BACE2 | |
| SCHEMBL31497385 | 0.91 | ERBB2 (0.48) | SIRT2SIRT5ERBB2BACE1BACE2 | |
| SCHEMBL31497319 | 0.90 | SIRT2 (0.47) | SIRT2SIRT5ERBB2BACE1BACE2 | |
| SCHEMBL31497337 | 0.89 | ERBB2 (0.50) | SIRT2SIRT5ERBB2BACE1BACE2 | |
| SCHEMBL31497393 | 0.88 | TASP1 (0.49) | SIRT2SIRT5ERBB2BACE1BACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4545551-A1 | PEPTIDE INHIBITOR AND USE THEREOF | Chengdu Brilliant Inspiration Biotherapeutics Co., Ltd (CN) | 2025-04-30 | — | — | EP | disclosed |